eLife (Mar 2022)

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial

  • Lerato E Magosi,
  • Yinfeng Zhang,
  • Tanya Golubchik,
  • Victor DeGruttola,
  • Eric Tchetgen Tchetgen,
  • Vladimir Novitsky,
  • Janet Moore,
  • Pam Bachanas,
  • Tebogo Segolodi,
  • Refeletswe Lebelonyane,
  • Molly Pretorius Holme,
  • Sikhulile Moyo,
  • Joseph Makhema,
  • Shahin Lockman,
  • Christophe Fraser,
  • Myron Max Essex,
  • Marc Lipsitch,
  • On behalf of The Botswana Combination Prevention Project and PANGEA consortium

DOI
https://doi.org/10.7554/eLife.72657
Journal volume & issue
Vol. 11

Abstract

Read online

Background: Mathematical models predict that community-wide access to HIV testing-and-treatment can rapidly and substantially reduce new HIV infections. Yet several large universal test-and-treat HIV prevention trials in high-prevalence epidemics demonstrated variable reduction in population-level incidence. Methods: To elucidate patterns of HIV spread in universal test-and-treat trials, we quantified the contribution of geographic-location, gender, age, and randomized-HIV-intervention to HIV transmissions in the 30-community Ya Tsie trial in Botswana. We sequenced HIV viral whole genomes from 5114 trial participants among the 30 trial communities. Results: Deep-sequence phylogenetic analysis revealed that most inferred HIV transmissions within the trial occurred within the same or between neighboring communities, and between similarly aged partners. Transmissions into intervention communities from control communities were more common than the reverse post-baseline (30% [12.2 – 56.7] vs. 3% [0.1 – 27.3]) than at baseline (7% [1.5 – 25.3] vs. 5% [0.9 – 22.9]) compatible with a benefit from treatment-as-prevention. Conclusions: Our findings suggest that population mobility patterns are fundamental to HIV transmission dynamics and to the impact of HIV control strategies. Funding: This study was supported by the National Institute of General Medical Sciences (U54GM088558), the Fogarty International Center (FIC) of the U.S. National Institutes of Health (D43 TW009610), and the President’s Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention (CDC) (Cooperative agreements U01 GH000447 and U2G GH001911).

Keywords